Human Genome Sciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Human Genome Sciences Inc inventory turnover ratio, the Human Genome Sciences Inc's ability to sell and replace its inventory in the second quarter 2012, sequentially increased to 1.24 in the second quarter 2012, a new company high. Average inventory processing period, for the Human Genome Sciences Inc in Jun 30 2012 quarter, has decreased to 294 days, compare to 487 days, in the Mar 31 2012 quarter.

Within Healthcare sector 197 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the first quarter 2012, to 1971.

HGSI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Human Genome Sciences Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HGSI Inventory Turnover Ratio	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter	(Jun 30 2011) II. Quarter
Y / Y Inventory Growth	-41.4 %	32.03 %	-3.32 %	-	-
Y / Y Cost of Sales Growth	223.01 %	68.12 %	-	48.29 %	116.61 %
Inventory Turnover Ratio (TTM)	1.24	0.75	-	0.6	0.75
HGSI's Total Ranking	# 1971	#	#	#	#
Average inventory processing period	296	485	-	612	489
Seq. Inventory Growth	-49.46 %	8.13 %	3.52 %	3.6 %	13.86 %
Seq. Cost of Sales Growth	11.66 %	-	-	-26.57 %	-41.88 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 9
Healthcare Sector	# 198
Overall Market	# 1971

Inventory Turnover Ratio Statistics
High	Average	Low
1.24	0.86	0.6
(Jun 30 2012)		(Dec 31 2011)

HGSI Company Profile >> Back to HGSI Efficiency Comparisons >> Compare HGSI Inventory Turnover Ratio to its Competitors

Financial Statements
Human Genome Sciences Inc's Inventories	$ 23 Millions	Visit HGSI's Balance sheet
Human Genome Sciences Inc's Cost of Revenues TTM	$ 46 Millions	Visit HGSI's Income Statement
What are HGSI's Sales?		Visit HGSI's Sales by Segment

Other Inventory Turnover Ratios
Human Genome Sciences Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HGSI's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HGSI's Competitors
Inventory Turnover Ratio for HGSI's Suppliers
Inventory Turnover Ratio for HGSI's Customers

You may also want to know
HGSI's Sales Growth Rates	HGSI's Pe Price to earnings ratio	HGSI's Receivables Turnover Ratio	HGSI's Stock Quote
HGSI's Net Income Growth Rates	HGSI's Ps Price to Sales ratio	HGSI's Sales per Employee	HGSI's Asset Turnover Ratio
HGSI's Net Margin	HGSI's Pb Price to Book ratio	HGSI's Financial Strength Ratios	HGSI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2012, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2012	Inventories at quarter ending Jun 30 2012
China Pediatric Pharmaceuticals, Inc.	5.40	$ 4.461 Millions	$ 1 Millions
Kewaunee Scientific Corporation	5.38	$ 61.360 Millions	$ 11 Millions
Perspective Therapeutics Inc	5.36	$ 3.290 Millions	$ 1 Millions
Bioxytran Inc	5.32	$ 0.084 Millions	$ 0 Millions
Cocrystal Pharma Inc	5.25	$ 13.118 Millions	$ 3 Millions
Steris Plc	5.06	$ 852.339 Millions	$ 169 Millions
Shengtai Pharmaceutical, Inc.	5.05	$ 109.934 Millions	$ 22 Millions
Enzo Biochem Inc	4.90	$ 45.119 Millions	$ 9 Millions
Nutrastar International Inc.	4.87	$ 6.444 Millions	$ 1 Millions
Henry Schein Inc	4.80	$ 4,589.770 Millions	$ 956 Millions
Cantel Medical Corp	4.75	$ 222.323 Millions	$ 47 Millions
Intuitive Surgical Inc	4.75	$ 544.500 Millions	$ 115 Millions
Invacare Holdings Corporation	4.69	$ 968.495 Millions	$ 207 Millions
Micron Solutions Inc	4.66	$ 15.163 Millions	$ 3 Millions
Luna Innovations Inc	4.58	$ 15.535 Millions	$ 3 Millions
Dexcom Inc	4.39	$ 33.005 Millions	$ 8 Millions
3m Company	4.35	$ 15,610.000 Millions	$ 3,588 Millions
Nuo Therapeutics, Inc.	4.31	$ 2.545 Millions	$ 1 Millions
Star Equity Holdings Inc	4.19	$ 25.494 Millions	$ 6 Millions
West Pharmaceutical Services Inc	4.18	$ 653.500 Millions	$ 156 Millions
Precipio inc	4.01	$ 12.441 Millions	$ 3 Millions
Sanomedics, Inc.	3.97	$ 0.139 Millions	$ 0 Millions
Carlisle Companies Incorporated	3.96	$ 2,090.300 Millions	$ 528 Millions
Complete Genomics Inc	3.94	$ 21.602 Millions	$ 5 Millions
Charles River Laboratories International inc	3.84	$ 354.422 Millions	$ 92 Millions
Pacira Biosciences inc	3.83	$ 16.537 Millions	$ 4 Millions
Teva Pharmaceutical Industries Limited	3.82	$ 9,723.000 Millions	$ 2,547 Millions
Medicines Co	3.82	$ 164.810 Millions	$ 43 Millions
Teligent Inc	3.78	$ 4.528 Millions	$ 1 Millions
Utah Medical Products Inc	3.76	$ 16.681 Millions	$ 4 Millions

Date modified: 2026-09-08T15:07:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.